19-22180015-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001001411.3(ZNF676):āc.1702A>Gā(p.Lys568Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,613,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001001411.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF676 | NM_001001411.3 | c.1702A>G | p.Lys568Glu | missense_variant | 3/3 | ENST00000397121.3 | NP_001001411.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF676 | ENST00000397121.3 | c.1702A>G | p.Lys568Glu | missense_variant | 3/3 | 2 | NM_001001411.3 | ENSP00000380310 | ||
ZNF676 | ENST00000650058.1 | c.1798A>G | p.Lys600Glu | missense_variant | 4/4 | ENSP00000497897 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000282 AC: 7AN: 248226Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134640
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461674Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727132
GnomAD4 genome AF: 0.000105 AC: 16AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2024 | The c.1702A>G (p.K568E) alteration is located in exon 3 (coding exon 3) of the ZNF676 gene. This alteration results from a A to G substitution at nucleotide position 1702, causing the lysine (K) at amino acid position 568 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at